Clinical Trials Logo

Neuritis clinical trials

View clinical trials related to Neuritis.

Filter by:

NCT ID: NCT02833142 Completed - Multiple Sclerosis Clinical Trials

Pharmacokinetics, Safety and Tolerability of Single Doses of BIIB033 (Opicinumab) Produced by 2 Manufacturing Processes

Start date: July 2016
Phase: Phase 1
Study type: Interventional

The primary objective of the study is to characterize the pharmacokinetics (PK) of BIIB033-B and to compare the PK profile with that of BIIB033-A in healthy volunteers. Secondary objectives are: To assess the safety and tolerability of BIIB033-A and BIIB033-B; To assess the secondary PK parameters of BIIB033-A and BIIB033-B; To assess the immunogenicity of BIIB033-A and BIIB033-B.

NCT ID: NCT02657915 Completed - Clinical trials for Acute Optic Neuritis

Long-Term Assessment of Remyelinating Therapy

RENEWED
Start date: March 10, 2016
Phase: Phase 2
Study type: Interventional

The primary objective of the study is to assess full-field visual evoked potential (FF-VEP) latency in subjects who were enrolled in Study NCT01721161 2 years (+ up to 12 months) after the last study visit. The secondary objective is to assess clinical progression and severity of central nervous system (CNS) demyelinating disease in subjects who were enrolled in Study NCT01721161 2 years (+ up to 12 months) after the last study visit. Intervention was administered in the previous study. The participants, investigator and outcome assessors remain blinded in this follow-up study.

NCT ID: NCT02655575 Active, not recruiting - Dizziness Clinical Trials

Assessment and Treatment of Patients With Long-term Dizziness in Primary Care

LODIP
Start date: October 2015
Phase: N/A
Study type: Interventional

Brief Summary: The purpose of the present study is to examine the effects of a Group based intervention consisting of vestibular rehabilitation (VR) combined with cognitive behavioral therapy (CBT) in patients with long--lasting vestibular dizziness. The study also aims to describe sociodemographic, physical and psychological characteristics in the patients, and to examine prognostic factors related to functional status and disability following participation in the intervention. Prior to the RCT, a feasibility study will be conducted to examine the feasibility of the study protocol.

NCT ID: NCT02573792 Completed - Optical Neuritis Clinical Trials

Optical Coherence Tomography and Optic Neuritis (OCTON)

OCTON
Start date: October 5, 2015
Phase:
Study type: Observational

Optic neuritis (ON) can remain isolated or reveal a widespread and chronic disease of the central nervous system (CNS), a multiple sclerosis (MS) or, more rarely, a Devic's neuromyelitis optica (NMO) or a systemic disease. The optical coherence tomography (OCT) is a retinal imaging technique to measure the thickness of the retina and its different layers with an accuracy of 4-6 µM. Costello et al have shown that approximately 75% of 54 MS patients have developed within 3 to 6 months after a ON a loss of 10 to 40 µM in the thickness of the peripapillary retinal nerve fiber layer (RNFL). The etiologic diagnosis of ON has been transformed in recent years. MS can now be diagnosed by McDonald's MRI criteria and NMO by the AQP4 antibodies (anti-aquaporin- 4) antibodies and the anti-MOG (myelin-oligodendrocyte glycoprotein) antibodies. The diagnosis and prognosis value of the OCT in patients with ON is not well known

NCT ID: NCT02556437 Completed - Clinical trials for Multifocal Motor Neuropathy

Efficacy and Safety of HyQvia (Immunoglobulin 10% With Recombinant Hyaluronidase) in Multifocal Motor Neuropathy (MMN)

Start date: June 2016
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of HyQvia (Immunoglobulin 10% with recombinant hyaluronidase) with conventional subcutaneous immunoglobulin treatment in patients with Multifocal Motor Neuropathy (MMN).

NCT ID: NCT02521311 Recruiting - Optic Neuritis Clinical Trials

Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

ReCOVER
Start date: February 28, 2017
Phase: Phase 2
Study type: Interventional

The main purpose of this study is to assess clemastine as a remyelinating agent in patients with acute optic neuritis.The study will also evaluate the tolerability of clemastine, originally approved as first-generation antihistamine, in patients with optic neuritis. Study procedures will include assessments for evidence of remyelination in the anterior visual pathway and in the brain using electrophysiologic techniques and magnetic resonance imaging. If they are on one, patients in this study can remain on their standard disease modifying treatment during the course of the study. However, patients cannot participate in any other investigational new drug research study concurrently.

NCT ID: NCT02220244 Active, not recruiting - Multiple Sclerosis Clinical Trials

Effect of MD1003 in Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis

MS-ON
Start date: October 2013
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate the superiority of MD1003 over placebo in the visual improvement of patients suffering from chronic visual loss resulting from multiple sclerosis related optic neuritis.

NCT ID: NCT02121678 Completed - Clinical trials for Chronic Inflammatory Demyelinating Polyneuropathy

Effect of Resistance and Aerobic Exercise in CIDP or MMN

Start date: April 2014
Phase: N/A
Study type: Interventional

Resistance and aerobic exercise has been shown to be effective for maintenance of muscle strength in patients with neuromuscular diseases. Exercise in CIDP and MMN is sparsely described. The aim of the study is to evaluate changes in muscle strength during high intensive resistance training and changes in maximal oxygen consumption (VO2-max) during high intensive aerobic training in patients with CIDP or MMN in maintenance therapy with subcutaneous immunoglobulin. The hypotheses are that muscle strength and VO2-max are significantly increased during the training sessions.

NCT ID: NCT02107417 Recruiting - Pain Clinical Trials

Study of TENS in Reducing Symptoms of Peripheral Neuropathy Induced by Chemotherapy

CIPN
Start date: June 2014
Phase: N/A
Study type: Interventional

This study aims to investigate the effects of Transcutaneous Electrical Nerve Stimulation (TENS) in reducing the symptoms of pain and numbness and improve the daily lives of cancer patients who have Chemotherapy-induced peripheral neuropathy (CIPN).

NCT ID: NCT02098330 Completed - Vestibular Neuritis Clinical Trials

The Efficacy of Steroid Therapy in Vestibular Neuritis

Start date: March 2014
Phase: Phase 3
Study type: Interventional

The purpose of this study was to compare the treatment effectiveness of steroid therapy for vestibular neuritis by using video head impulse test.